Changes in Annual CA-125 Tests' Results May Provide Effective Detection for Early-Stage Ovarian Cancer (5.28.10)
Department of Gynecologic Oncology University of Texas M. D. Anderson Cancer Center, Houston, Texas recently provided data showing that the change in CA-125 test results for a patient over time may an effective screening tool for detecting the early stage of ovarian cancer. Diagnosing and treating ovarian cancer has long plagued science as it generally is not discovered until it has progressed to a fatal stage. With these new findings, it is hoped that the majority of ovarian cancer victims will be diagnosed early on and allow a far greater chance of survival.
SOURCE: University of Texas M. D. Anderson Cancer Center